Leszek Szenborn

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Peter Richmond, Helen Marshall, Michael D. Nissen et al. · The Lancet Infectious Diseases · 2012 · 130 citations

Vaccination, Vaccine Safety, Healthy Adolescents +6

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

Karen F. Murray, Leszek Szenborn, Jacek Wysocki et al. · Hepatology · 2012 · 125 citations · Full text

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

Nancy Bermal, Leszek Szenborn, Andrzej Chrobot et al. · The Pediatric Infectious Disease Journal · 2009 · 93 citations

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants

Félix Omeñaca, J Sarlangue, Leszek Szenborn et al. · The Pediatric Infectious Disease Journal · 2012 · 64 citations

A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial

Stan L. Block, Leszek Szenborn, Wendy Daly et al. · Vaccine · 2015 · 57 citations

Vaccination, Vaccine Safety, Vaccine Efficacy +7